92 related articles for article (PubMed ID: 4346725)
1. [Results of treatment of solid tumors with massive levels of methotrexate and folinic acid combination. Apropos of 49 cases].
Cheix-Servonnat F; Auboyer C; Bonnafous N; Pommatau E
Sem Hop; 1973 Jan; 49(2):143-8. PubMed ID: 4346725
[No Abstract] [Full Text] [Related]
2. [A policy followed by therapeutic trials in the problem of chemotherapy of otorhinolaryngologic intra-arterial tumors].
Sancho H; Richard JM
Bull Cancer; 1974; 61(2):257-63. PubMed ID: 4619028
[No Abstract] [Full Text] [Related]
3. [Action of massive doses of cyanocobalamin in otorhinolaryngologic neoplasms].
Natali R
Ann Otolaryngol Chir Cervicofac; 1969; 86(7):501-5. PubMed ID: 4187129
[No Abstract] [Full Text] [Related]
4. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
5. [Clinical experiences with Benzyrin for otorhinolaryngological tumors].
Kawabe Y; Watanabe Y; Kondo T
Jibiinkoka; 1968 Apr; 40(4):335-8. PubMed ID: 5748637
[No Abstract] [Full Text] [Related]
6. [High doses of methotrexate followed by folinic acid in acute leukemia and solid tumors].
Fiere D; Bryon PA; Dechavanne M; Guyon JM; Revol L
Lyon Med; 1970 Apr; 223(15):805-8. PubMed ID: 5310097
[No Abstract] [Full Text] [Related]
7. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
[No Abstract] [Full Text] [Related]
8. [Our experience with endoxan in the treatment of otorhinolaryngological tumors].
Kubović M; Subotić R
Lijec Vjesn; 1964 Dec; 86(12):1531-5. PubMed ID: 5860251
[No Abstract] [Full Text] [Related]
9. Improved therapeutic index of methotrexate with "leucovorin rescue".
Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR
Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of epitheliomas of the otorhinolaryngological and cervicofacial area using bleomycin].
Leroux-Robert J; Graverol MT; Villedrouin J
Ann Otolaryngol Chir Cervicofac; 1972; 89(4):201-18. PubMed ID: 4116540
[No Abstract] [Full Text] [Related]
11. Re-evaluation of methotrexate as an anticancer drug.
Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
[No Abstract] [Full Text] [Related]
12. Prolonged intravenous methotrexate therapy in the treatment of acute leukemia and solid tumors.
Gottlieb JA; Serpick AA
Cancer Res; 1970 Aug; 30(8):2132-8. PubMed ID: 5311765
[No Abstract] [Full Text] [Related]
13. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
Khoo SK; Jones IS
Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
[TBL] [Abstract][Full Text] [Related]
14. Toxic and therapeutic effects of methotrexate-folinic acid (Leucovorin) in advanced cancer and leukemia.
Vogler WR; Jacobs J
Cancer; 1971 Oct; 28(4):894-901. PubMed ID: 5315548
[No Abstract] [Full Text] [Related]
15. Treatment of basal and squamous cancers of the nose and ear with 5-fluorouracil cream.
Litwin MS; Krementz ET
Laryngoscope; 1971 Jun; 81(6):840-7. PubMed ID: 5091318
[No Abstract] [Full Text] [Related]
16. [High dose of methotrexate-leucovorin treatment in advanced non-Hodgkin's lymphoma].
Kawarabayashi K; Yoshikawa T; Sannomiya Y; Hashimoto K; Araki J; Park K; Tatumi Y; Kamitani T; Im T; Tatumi N
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2493-9. PubMed ID: 6606395
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
19. [Long-term follow-up results of chemotherapy of tumors localized in otolaryngologic region in combination with surgical and x-ray therapy].
Uchytil B; Mechl Z
Cesk Otolaryngol; 1971 Jun; 20(3):120-4. PubMed ID: 5564733
[No Abstract] [Full Text] [Related]
20. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
